Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 469-474

  Vonk, Alieke G ^a   Netea, Mihai G ^a   Deneckert, Nathalie E J ^a,b   Verschueren, Ineke C M M ^a   Van Der Meer, Jos W M ^a   Kullberg, Bart Jan ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANDIDA ALBICANS; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEVER; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MONONUCLEAR CELL; NORMAL HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; NEUTROPHIL ACTIVATION; NEUTROPHILS; RNA, MESSENGER; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031714371     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.469     Document Type: Article

References (25)

1. Lyman, C. A. & Walsh, T. J. (1992). Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications. Drugs 44, 9-35.
2. Martin, E., Stuben, A., Gorz, A., Weller, U. & Bhakdi, S. (1994). Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrobial Agents and Chemotherapy 38, 13-22.
3. Perfect, J. R., Granger, D. L. & Durack, D. T. (1987). Effects of antifungal agents and γ interferon on macrophage cytotoxicity for fungi and tumor cells. Journal of Infectious Diseases 156, 316-23.
4. Lynn, W. A. & Cohen, J. (1995). Adjunctive therapy for septic shock: a review of experimental approaches. Clinical Infectious Diseases 20, 143-58.
5. Tokuda, Y., Tsuji, M., Yamazaki, M., Kimura, S., Abe, S. & Yamaguchi, H. (1993). Augmentation of murine tumour necrosis factor production by amphotericin B in vitro and in vivo. Antimicrobial Agents and Chemotherapy 37, 2228-30.
6. Chia, J. K. S. & McManus, E. J. (1990). In-vitro tumour necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations. Antimicrobial Agents and Chemotherapy 34, 906-8.
7. Chia, J. K. S. & Pollack, M. (1989). Amphotericin B induces tumour necrosis factor production by murine macrophages. Journal of Infectious Diseases 159, 113-6.
8. Cleary, J. D., Chapman, S. & Nolan, R. L. (1992). Pharmacologic modulation of interleukin-1 expression by amphotericin B-stimulated human mononuclear cells. Antimicrobial Agents and Chemotherapy 36, 977-81.
9. Louie, A., Baltch, A. L., Franke, M. A., Smith, R. P. & Gordon, M. A. (1994). Comparative capacity of four antifungal agents to stimulate murine macrophages to produce tumour necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. Journal of Antimicrobial Chemotherapy 34, 975-87.
10. Raponi, G., Ghezzi, M. C., Mancini, C. & Filadoro, F. (1993). Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes. Antimicrobial Agents and Chemotherapy 37, 1958-61.
11. Ghezzi, M. C., Raponi, G., Filadoro, F. & Mancini, C. (1994). The release of TNF-α and IL-6 from human monocytes stimulated by filtrates of Candida albicans after treatment with amphotericin B. Journal of Antimicrobial Chemotherapy 33, 1039-43.
12. Netea, M. G., Hancu, N., Blok, W. L., Grigorescu-Sido, P., Popa, L., Popa, V. et al. (1997). Interleukin 1β, tumour necrosis factor-β and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals. Cytokine 9, 284-7.
13. Casini-Raggi, V., Kam, L., Chong, Y. J. T., Fiocchi, C., Pizarro, T. T. & Cominelli, F. (1995). Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. Journal of Immunology 154, 2434-40.
14. Chomarat, P., Vannier, E., Dechanet, J., Rissoan, M. C., Banchereau, J., Dinarello, C. A. et al. (1995). Balance of IL-1 receptor antagonist/IL-1β in rheumatoid synovium and its regulation by IL-4 and IL-10. Journal of Immunology 154, 1432-9.
15. Miller, L. C., Lynch, E. A., Isa, S., Logan, J. W., Dinarello, C. A. & Steere, A. C. (1993). Balance of synovial fluid IL-β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341, 146-8.
16. Endres, S., Ghorbani, R., Lonnemann, G., van der Meer, J. W. M. & Dinarello, C. A. (1988). Measurement of immunoreactive interleukin-1β from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clinical Immunology and Immunopathology 49, 424-38.
17. Drenth, J. P. H., van Uum, S. H. M., van Deuren, M., Pesman, G. J., Van der Ven-Jongekrijg, J. & van der Meer, J. W. M. (1995). Endurance run increases circulating IL-6 and IL-1ra but down-regulates ex vivo TNF-α and IL-α production. Journal of Applied Physiology 79, 1497-503.
18. Netea, M. G., Drenth, J. P. H., De Bont, N., Hijmans, A., Keuter, M., Dharmana, E. et al. (1996). A semi-quantitative reverse transcriptase polymerase chain reaction method for measurement of mRNA for TNF-α and IL-β in whole blood cultures: its application in typhoid fever and eccentric exercise. Cytokine 8, 739-44.
19. Louie, A., Baltch, A. L., Smith, R. P., Franke, M. A., Ritz, W. J., Singh, J. K. et al. (1995). Fluconazole and amphotericin B anti-fungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis. Journal of Infectious Diseases 171, 406-15.
20. Arning, M., Kliche, A. H., Heer-Sonderhoff, A. H. & Wehmeier, A. (1995). Infusion-related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels. Mycoses 38, 459-65.
21. Sculier, J. P. & Body, J. J. (1991). Intravenous administration of amphotericin B entrapped in liposomes: induction of high serum levels of TNFα. Annals of Oncology 2, 141-4.
22. Al-Bassam, T., Poulain, D., Giumelly, P., Lematre, J. & Bonaly, R. (1985). Chemical and antigenic alterations of Candida albicans cell walls related to the action of amphotericin B sub-inhibitory doses. Journal of Antimicrobial Chemotherapy 15, 263-9.
23. Vecchiarelli, A., Puliti, M., Torosantucci, A., Cassone, A. & Bistoni, F. (1991). In-vitro production of tumour necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cellular Immunology 134, 65-76.
24. Fischer, W., Koch, H. U. & Haas, R. (1983). Improved preparation of lipoteichoic acids. European Journal of Biochemistry 133, 523-30.
25. Kusunoki, T., Hailman, E., Juan, T. S., Lichenstein, H. S. & Wright, S. D. (1995). Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. Journal of Experimental Medicine 182, 1673-82.